You’re Not Alone.
Every appointment created more uncertainty. We felt overwhelmed, unheard, and alone in trying to find answers for our child. Today, we finally understand what we’re facing, have a plan for what comes next, and know we don’t have to navigate it alone.
For Families
You've probably been at this for a while.
Maybe your child has seen three doctors. Maybe you've been told to "wait and see" more times than you can count. Maybe you already know something is wrong and you just need someone to help you find out what.
You are in the right place. And you are not the only one who has sat exactly where you're sitting right now.
Jura exists for this moment. We help families get whole genome sequencing, the most complete genetic test available, and we walk with you through every step of what comes next. That includes helping you get the order together, navigate insurance, understand your results, and figure out where to go from here.
You don't have to know anything about genetics to start. You just have to be willing to take the next step.
“In Medicine, rare conditions are often called zebras. We’re here for the zebras.”
What to expect
The more we know, the better. Before any test is ordered, our team wants to understand your situation. What you've already been through. What questions you most need answered.
Pre-test genetic counseling comes first. A genetic counselor will explain what whole genome sequencing can and cannot tell you, what kinds of results may come back, and what choices you may need to make before testing begins.
The test is simple. Whole genome sequencing starts with a saliva or cheek swab done in your home. We handle the logistics of getting the kit to you, supporting sample collection, and getting results back to you and your doctor. Most families have results within five weeks. If you have questions about collecting the sample or returning the kit, our team can help.
We don't disappear after results. This is the part that makes Jura different. When your results are ready, a genetic counselor talks with you directly to walk you through what they mean in plain language, not medical jargon. Your provider receives the full report, too, and genetic counselors and geneticists are available to support them before and after the test. Jura also provides personalized next-step resources to help you understand what steps to consider next and what to discuss with your child’s care team.
“In Medicine, rare conditions are often called zebras. We’re here for the zebras.”
Insurance Help
We know insurance can feel like another fight. Here's help.
We've put together tools to help you request coverage, respond to denials, and appeal decisions. You don't have to figure this out alone.
Request for Coverage Approval: Outpatient Diagnostic Whole Genome Sequencing (WGS)
This template can be used to provide rationale for coverage based on medical and medicaid guidelines
Sample Letter of Appeal
A template you may use if your insurance company has denied coverage for genetic or genomic testing. This resource can help you organize and communicate your appeal.
Commonly Referenced Medical Guidelines
American College of Medical Genetics and Genomics (ACMG)
Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
American Academy of Pediatrics Guidelines
The American Academy of Pediatrics’ June 23, 2025 clinical report supports a genetics-first approach when evaluating children with intellectual disability or global developmental delay. Based on input from academic clinicians, families and care teams are encouraged to include this document with insurance submissions or appeals to help support the medical need for genomic testing.
Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disorders
A comprehensive evidence review shows that using genome sequencing as a first-line diagnostic test for rare genetic disorders significantly improves diagnostic yield and clinical decision-making compared with traditional stepwise testing, supporting earlier, more effective care.
Commonly Referenced Economic Justification
The Cost of Delayed Diagnosis in Rare Disease: A Health Economic Study
A landmark report showing the cost savings of receiving a more timely diagnosis in rare diseases. The economic impact of a delayed diagnosis is up to $517,000 in avoidable costs per patient. Shortening the more than six-year average diagnostic odyssey saves money for individuals, caregivers, and the healthcare system, while improving health outcomes.
Still have questions?
Call or email us. A real person will respond.
Email: info@jura.health
Phone: (888) 420-0507